St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy
This article was originally published in The Gray Sheet
St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging
You may also be interested in...
Rights for Abbott to promote and distribute intravascular optical coherence tomography imaging and fractional flow reserve products from St. Jude Medical are added to an existing co-promotion pact between the firms.
One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.
With innovation as the theme of this year's EuroPCR meeting, emerging technology sessions and innovation presentations sparked lively discussions. While drug-eluting stents remained a key interest area, transcatheter aortic heart valve implantation sessions drew the largest crowds.